Literature DB >> 791485

The genus Cephalotaxus: source of homoharringtonine and related anticancer alkaloids.

C R Smith, R G Powell, K L Mikolajczak.   

Abstract

Various phases of research on Ciphalotaxus alkaloids are summarized, including their discovery, nature of antitumor activity, isolation, structural characterization, synthesis, biogenesis, and mechanism of physiologic action.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 791485

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


  5 in total

1.  Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia.

Authors:  Rong Chen; Lei Guo; Yuling Chen; Yingjun Jiang; William G Wierda; William Plunkett
Journal:  Blood       Date:  2010-10-22       Impact factor: 22.113

2.  Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia.

Authors:  Liu-Fang Gu; Wang-Gang Zhang; Fang-Xia Wang; Xing-Mei Cao; Yin-Xia Chen; Ai-Li He; Jie Liu; Xiao-Rong Ma
Journal:  J Cancer Res Clin Oncol       Date:  2010-12-09       Impact factor: 4.553

3.  Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.

Authors:  L J Wilkoff; D A Dulmadge; W R Laster; D P Griswold
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study.

Authors:  Xiaorong Ma; Jin Wang; Yan Xu; Wanggang Zhang; Jie Liu; Xingmei Cao; Aili He; Fangxia Wang; Liufang Gu; Bo Lei; Jianli Wang
Journal:  Onco Targets Ther       Date:  2016-06-20       Impact factor: 4.147

5.  Small-molecule induction of phospho-eIF4E sumoylation and degradation via targeting its phosphorylated serine 209 residue.

Authors:  Ying Gu; Hong Zhou; Yichao Gan; Jiawei Zhang; Jianghua Chen; Xiaoxian Gan; Hongzhi Li; Weiwei Zheng; Zhipeng Meng; Xiaoxiao Ma; Xichun Wang; Xiaohua Xu; Ganyu Xu; Xiaoya Lu; Yun Liang; Xuzhao Zhang; Xinliang Lu; Wendong Huang; Rongzhen Xu
Journal:  Oncotarget       Date:  2015-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.